The Oxford Risk Factors And Non-Invasive Imaging Study
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- University of Oxford
- Study ID
- NCT05169333
- Status
- Recruiting
Conditions
- Cardiovascular Diseases
- Cardiovascular Risk Factors
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Study Details
ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.
Key Dates
- Start date
- Feb 23, 2016
- Status verified
- Dec 2024
- Primary completion
- Feb 28, 2030
- Completion
- Feb 28, 2030
Study Design
- Enrollment
- 250,000 participants (estimated)
Arms
- Arm: Group 1Participants attending cardiology department, hypertension or outpatient clinics.
- Arm: Group 2Participants who are recruited prospectively, during their clinically indicated CT scan, and they are followed-up prospectively for clinical endpoints; A follow-up CCTA at least 6 months later will be offered to a subgroup of these patients, to assess disease progression.
- Arm: Group 3Individuals where at least 6 months have elapsed from previous CCTA will undergo repeat CCTA scan and enter prospective follow up for clinical endpoints.
- Arm: Group 4Cohort of consecutive patients who have undergone clinical CTAs or unenhanced CT chest, abdomen and pelvis in the past, linking the index CT scan with prospective outcomes collection already accumulated.
Primary Outcome Measure
Cardiac and all cause mortality [ Time Frame: 15 years ]
Central Contacts
- Kenneth Chan
- Charalambos Antoniades
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NIH National Heart, Lunch, and Blood Institute | Bethesda | Maryland | - | - |
| Mayo Clinic | Rochester | Minnesota | - | - |
| Cleveland Clinic Heart and Vascular Institute | Cleveland | Ohio | - | - |
Find similar trials in Bethesda, MD
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Mayo AVC Registry and BiobankRecruiting · Mayo Clinic · Rochester, Minnesota
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona